Bioanalytics – Biomolecular
Lauren Stevenson, PhD
Chief Scientific Officer
Immunologix Laboratories
Tampa, USA, Florida
Amanda Hays, Ph.D.
Scientific Officer
BioAgilytix
Olathe, Kansas
Scarcity caused by supply chain issues during the Covid 19 pandemic prompted industry-wide rethinking regarding appropriate assay matrices. However, this question merits broader consideration. This presentation will delve into the scientific rationale regarding the preference for 'authentic' matrices and will use real world examples to question conventional wisdom, challenge past assumptions, and propose approaches that ensure sound science while simultaneously raising the bar for responsible, ethical utilization of resources with focus on cost-benefit for patients.